Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Terra

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Clinical Pharmacology and Therapeutics|May 28, 2015
Type 2 Diabetes: Progress Made but Still a Long Road to Travel to Reduce Disease BurdenS G Terra, J Vincent
The Annals of Pharmacotherapy|June 1, 1997
Medroxyprogesterone acetate in the treatment of obstructive sleep apneaS G Terra, K C Oberg
The Annals of Pharmacotherapy|November 24, 1998
Opioid antagonists in the treatment of pruritus from cholestatic liver diseaseS G Terra, S M Tsunoda
Pharmacotherapy|November 5, 1997
A review of tissue plasminogen activator in the treatment of veno-occlusive liver disease after bone marrow transplantationS G Terra, T R Spitzer, S M Tsunoda
The Annals of Pharmacotherapy|October 30, 1998
Comment: troglitazone drug interactionsS G Terra, J B Washam, D B May
Pharmacotherapy|October 8, 1999
Therapeutic range of digoxin's efficacy in heart failure: what is the evidence?S G Terra, J B Washam, G D Dunham, et al.
Journal of Clinical Pharmacology|July 14, 2017
The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes MellitusV Sahasrabudhe, S G Terra, A Hickman, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|April 8, 2011
A Dose-Ranging Study of the DPP-IV Inhibitor PF-734200 Added to Metformin in Subjects With Type 2 Diabetes*S G Terra, V Somayaji, S Schwartz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 12, 2011
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetesJ Rosenstock, A J Lewin, P Norwood, et al.
The Pharmacogenomics Journal|February 7, 2008
Beta-adrenergic receptor gene polymorphisms and hemodynamic response to dobutamine during dobutamine stress echocardiographyC L Aquilante, H N Yarandi, L H Cavallari, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|May 28, 2015
Type 2 Diabetes: Progress Made but Still a Long Road to Travel to Reduce Disease BurdenS G Terra, J Vincent
The Annals of Pharmacotherapy|June 1, 1997
Medroxyprogesterone acetate in the treatment of obstructive sleep apneaS G Terra, K C Oberg
The Annals of Pharmacotherapy|November 24, 1998
Opioid antagonists in the treatment of pruritus from cholestatic liver diseaseS G Terra, S M Tsunoda
Pharmacotherapy|November 5, 1997
A review of tissue plasminogen activator in the treatment of veno-occlusive liver disease after bone marrow transplantationS G Terra, T R Spitzer, S M Tsunoda
The Annals of Pharmacotherapy|October 30, 1998
Comment: troglitazone drug interactionsS G Terra, J B Washam, D B May
Pharmacotherapy|October 8, 1999
Therapeutic range of digoxin's efficacy in heart failure: what is the evidence?S G Terra, J B Washam, G D Dunham, et al.
Journal of Clinical Pharmacology|July 14, 2017
The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes MellitusV Sahasrabudhe, S G Terra, A Hickman, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|April 8, 2011
A Dose-Ranging Study of the DPP-IV Inhibitor PF-734200 Added to Metformin in Subjects With Type 2 Diabetes*S G Terra, V Somayaji, S Schwartz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 12, 2011
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetesJ Rosenstock, A J Lewin, P Norwood, et al.
The Pharmacogenomics Journal|February 7, 2008
Beta-adrenergic receptor gene polymorphisms and hemodynamic response to dobutamine during dobutamine stress echocardiographyC L Aquilante, H N Yarandi, L H Cavallari, et al.
Pageof 2